Epidemiological studies suggest that HSV-2 increases the risk of HIV-1 acquisition. 1, 2, 3 In populations with HSV-2 prevalence of 80%, nearly 50% of HIV-1 infections are attributable to an HSV-2 ...

Persons who have tested positive for herpes simplex virus type 2 (HSV-2) but do not have symptoms or genital lesions still experience virus shedding during subclinical (without clinical manifestations ...

Herpes simplex virus 2 (HSV-2) is a sexually transmitted infection that can cause painful, recurrent lesions in the genital skin and mucosa. HSV-2 initially infects genital epithelial cells before ...

Ex vivo analysis of these cells allows unbiased characterization of the cellular composition, function, and phenotype of the local T-cell response to HSV-2. In the present study, we obtained cervical ...

Vaccines are one of the most important medical inventions of modern times that have saved and enhanced innumerable lives around the world. Despite the technological advances in vaccine design and ...

Genital herpes is one of the most common types of sexually transmitted infections (STI) in the United States – as well as one of the most frustrating. Characterized by periodic blisters on the ...

Genocea Biosciences announced today that it has initiated a Phase 1/2a clinical study with its lead candidate, GEN-003. GEN-003 is an investigational vaccine designed to stimulate T cell and B cell ...

COBAS ANALYZER for use with Elecsys HSV-1 IgG and HSV-2 IgG Assays by Roche Roche announced that it has received clearance from the FDA for its IgG Antibody to herpes simplex virus (HSV) types 1 and 2 ...

Serum YKL-40 levels in patients with cervical cancer are elevated compared to patients with cervical intraepithelial neoplasia and healthy controls No significant financial relationships to disclose.

Quest Diagnostics announced that the FDA has cleared Focus Diagnostics’ new Simplexa HSV 1 & 2 Direct molecular test with a CLIA moderate complexity categorization. Simplexa is the first FDA-cleared ...